Concerns Over CDC Communication on Covid-19 Vaccines

In a recent email obtained by the Post, officials at the Centers for Disease Control and Prevention (CDC) seem to have downplayed public worries about the Covid-19 vaccine’s effectiveness. They reportedly discussed strategies to prevent a “too accurate” comparison between the benefits of vaccination and natural immunity.

The email indicates that agency leaders held multiple meetings focused on public relations tactics, revealing their struggle to provide comprehensive information about vaccine safety and effectiveness against SARS-CoV-2.

On September 22, 2023, the Covid Coordination Unit collaborated through email to brainstorm ways to better illustrate the varying risks of severe illness for Americans, depending on their vaccination status and protective measures taken.

One message from the address “covidtransition@cdc.gov” noted, “I don’t want the visualization to be too accurate so that people can guess the exact risk or protection score.”

Almost 600 pages of internal documents, disclosed by the Public Health Reform Alliance under the Freedom of Information Act, provide further insights into these discussions.

This revelation comes amid several public turns regarding the efficacy of masks, the question of airborne transmission of the virus, and the protection offered by innate immunity compared to vaccination.

A report from a House Republican panel in October noted that the U.S. Department of Health and Human Services (HHS), which oversees the CDC, allocated $911 million for a Covid vaccine promotion campaign that misrepresented the effectiveness of various Covid prevention methods.

This disclosure followed the controversial firing of Susan Monares, the Trump-appointed CDC director, by HHS Secretary Robert F. Kennedy Jr. over vaccine policies.

The Covid Coordination Unit eventually created graphics indicating that measures like cloth masks and improved ventilation provided some level of protection against infections.

Interestingly, this visual aid was developed over a year and a half after initial findings suggested that natural immunity might be more effective at preventing repeated infections than vaccines alone. This shift in perspective highlighted a change in the CDC’s approach, recognizing that while vaccines might not completely prevent infections, they could mitigate severe illness.

By January 2024, CDC communications specialists had prepared answers to questions around mRNA vaccine technology, though they did not address state-level queries regarding safety and efficacy.

During this time, Florida’s Surgeon General Dr. Joseph Ladapo raised concerns about potential risks associated with the mRNA vaccines, citing the possibility of DNA integration from small DNA fragments present in the vaccine.

He stated, “If the risk of DNA integration is not evaluated for mRNA Covid-19 vaccines, these vaccines are not suitable for human use.”

A CDC spokesperson later categorized these DNA integration concerns as “misinformation,” advising that misinformation could exploit public fears and calling for a focus on factual information to keep communities informed.

In a recent conference, it became evident that further research into these areas might not be prioritized, despite internal documents suggesting that safety concerns weren’t being adequately considered.

Martin Hoyt, director of the Public Health Reform Alliance, criticized the CDC, claiming it operated more as a public relations entity for vaccine manufacturers rather than a scientific organization. He argued that the agency ignored legitimate safety concerns, obstructed the truth, and engaged in propaganda rather than genuine science.

Since then, Florida has become notable for being the first state in 2022 to halt recommendations for Covid vaccinations in healthy children, a stance echoed by the Trump administration for children and pregnant women.

On Monday, the President expressed that the CDC’s refusal to share information on the vaccine’s effectiveness has damaged the agency’s credibility and public trust.

He remarked that there’s pressure on pharmaceutical companies to validate the effectiveness of various Covid treatments, with some viewing the vaccines as miraculous and others remaining skeptical. “I’ve seen extraordinary information from Pfizer and others, but they don’t appear to make their results public. Why is that?” he questioned.

The CDC has yet to respond to inquiries regarding these issues.